Novagali Pharma SA

Novagali Pharma SA (Novagali Pharma) is an medical device company engaged in developing and manufacturing ocular drug delivery products. The company has developed two proprietary technologies namely, Novasorb and Eyeject. The Novasorb technology is a cationic emulsion developed for treatment of topical ocular drug administration. The Eyeject technology is designed for minimally-invasive approach to administer active compounds to the back of the eye. The company is developing a broad pipeline of seven innovative products based on its proprietary technology for the treatment of mild dry eye, severe dry eye, glaucoma, inflammation, eye allergy and diabetic retinopathy. The operational business of the company includes Europe, Japan and the US. Novagali Pharma is headquartered in Evry Cedex, France.

Street: 
1 rue Pierre Fontaine
City: 
Evry cedex
Postcode: 
F-91058
Federal State : 
France
WebSite: 
www.novagali.com
Fax: 
33-1-69874030

Company Index Score

Current Index Score Historical Index Score
  • Novagali Pharma SA currently scores 50 % in the index.
  • Novagali Pharma SA is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Novagali Pharma SA is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets